QuVa Pharma, Inc., a newly formed national platform for sterile compounding pharmacy services, acquired the assets of Unique Pharmaceuticals, Ltd., including its manufacturing facility in Temple, Texas.
The financial terms of the transaction were not disclosed. In conjunction with the deal, Travis Leeah, President of Unique Pharmaceuticals, will join QuVa Pharma’s management team.
Led by Stuart Hinchen, co-founder and Chief Executive Officer, and Peter Jenkins, co-founder and Chief Development Officer, QuVa Pharma is newly formed sterile compounding pharmacy services company.
With the acquisition, the company is addressing supply shortage issues that routinely and adversely impact the industry, and securing available capacity in a second location.
QuVa Pharma received a majority equity commitment from Bain Capital Private Equity as part of its formation in August.
FinSMEs
03/11/2015